Literature DB >> 23458767

Diagnostic and prognostic markers in sepsis.

Jean-Louis Vincent1, Marjorie Beumier.   

Abstract

Sepsis is a common and serious complication in intensive care unit patients. An important factor in optimizing survival rates in septic patients is the ability to start treatment early in the course of disease; there is, therefore, a need for accurate diagnostic tests. In recent years, there has been a move away from the rather vague and nonspecific signs that were previously used to diagnose sepsis towards the possible adjunctive role of biomarkers. Many biomarkers have been proposed and assessed clinically, but none alone is specific enough to definitively determine diagnosis. The future direction of research is most likely a greater focus on the use of panels or combinations of markers with clinical signs. Some biomarkers may also be useful for prognosis and guiding therapy. Here, the authors will review our changing approaches to sepsis diagnosis and discuss some of the markers that seem most relevant at the present time.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458767     DOI: 10.1586/eri.13.9

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  21 in total

Review 1.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

2.  Role of Automated Volume, Conductivity and Scatter (VCS) Parameters of Neutrophils as Indicators of Sepsis.

Authors:  Shruti Vaswani; Naveen Kakkar; Kanwardeep Singh Kwatra; Mary John
Journal:  Indian J Hematol Blood Transfus       Date:  2022-01-29       Impact factor: 0.915

3.  Immunocompromised hosts: Infections and biomarkers.

Authors:  Atul P Kulkarni
Journal:  South Asian J Cancer       Date:  2013-10

4.  The intensive care infection score - a novel marker for the prediction of infection and its severity.

Authors:  Patrick J van der Geest; Mostafa Mohseni; Jo Linssen; Servet Duran; Robert de Jonge; A B Johan Groeneveld
Journal:  Crit Care       Date:  2016-07-07       Impact factor: 9.097

5.  Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.

Authors:  Sun Bean Kim; Kyoung Hwa Lee; Ji Un Lee; Hea Won Ann; Jin Young Ahn; Yong Duk Jeon; Jung Ho Kim; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

6.  The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII.

Authors:  Theresia Reding; Cristian Palmiere; Clinsyjos Pazhepurackel; Marc Schiesser; Daniel Bimmler; Andrea Schlegel; Ursula Süss; Sabrina Steiner; Leandro Mancina; Gitta Seleznik; Rolf Graf
Journal:  Oncotarget       Date:  2017-05-02

Review 7.  The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.

Authors:  Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman
Journal:  Intensive Care Med Exp       Date:  2021-07-02

Review 8.  Biomarkers for sepsis.

Authors:  Cesar Henriquez-Camacho; Juan Losa
Journal:  Biomed Res Int       Date:  2014-03-30       Impact factor: 3.411

9.  The Clinical Challenge of Sepsis Identification and Monitoring.

Authors:  Jean-Louis Vincent
Journal:  PLoS Med       Date:  2016-05-17       Impact factor: 11.069

10.  Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?

Authors:  Nur Efe İris; Taner Yıldırmak; Habip Gedik; Funda Şimşek; Demet Aydın; Naciye Demirel; Osman Yokuş
Journal:  Turk J Haematol       Date:  2016-06-27       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.